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Abstract 
Metabolomics involves the large scale analysis of metabolites and thus, provides 
information regarding cellular processes in a biological sample. Independently of the 
analytical technique used, a vast amount of data is always acquired when carrying out 
metabolomics studies; this results in complex datasets with large amounts of variables. This 
type of data requires multivariate statistical analysis for its proper biological interpretation. 
Prior to multivariate analysis, preprocessing of the data must be carried out to remove 
unwanted variation such as instrumental or experimental artifacts. This review aims to outline 
the steps in the preprocessing of NMR metabolomics data and describe some of the methods 
to perform these. Since using different preprocessing methods may produce different results, 
it is important that an appropriate pipeline exists for the selection of the optimal combination 
of methods in the preprocessing workflow.  
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Introduction 
Metabolism is the set of enzymatic biochemical reactions necessary for life processes to 
take place in living organisms[1]. Metabolomics involves the large scale analysis of 
metabolites, which are the products and/or intermediates of metabolism[2]. They include 
substances like carbohydrates, amino acids, nucleotides and vitamins[3]. Most metabolites are 
molecules of 1000 Da or lower in size; however, some large molecules, like lipoproteins and 
albumin, may fall into this group of substances[2].  
Metabolites can be classified into different groups according to the field of study. In plant 
metabolomics, a metabolite can be either primary or secondary. Primary metabolites are 
involved in life-preserving functions related to growth, development and reproduction[4]. 
Although secondary metabolites are not directly crucial for short-term survival, they play a 
significant ecological role, usually related to plant defense[4]. Human metabolomics divides 
metabolites into endogenous and exogenous, the former being synthetized by the host 
organism while the latter originate from external substances like food or drugs. This review 
focuses on endogenous human metabolomics of biofluids and tissue. The collection of small-
molecule metabolites present in a biological organism makes up its metabolome, which is a 
term parallel to the genome, transcriptome and proteome[5]. The metabolome gives insight on 
the physiological state of a cell or organism at a particular moment, under given conditions. It 
is dynamic: constantly changing due to the influence of extragenomic factors like 
environment, diet, toxins, disease processes, etc.  
Daviss defines metabolomics as “the study of the unique chemical fingerprints that 
specific cellular processes leave behind”[6]. It is a relatively new field that can be considered 
the final step in the omics cascade, after genomics, transcriptomics and proteomics[7] (Figure 
1). The omics cascade illustrates the biochemical information exchange between the different 
molecular levels in an organism, starting with the level of genes to the last level of 
  
metabolites. Because the metabolome is affected by post transcriptional and post translational 
events, such as environmental factors, when compared to these top three levels, metabolomic 
profiles provide information at a level that is closer to the phenotype[8]. Furthermore, these 
profiles can be useful in the early detection of a normal, healthy state becoming 
dysfunctional[9, 10]. The types and quantities of metabolites that make up these profiles 
depend on the condition of the living organism or cell they belong to, which makes it possible 
to establish metabolic differences between different states, gain insight on the biochemical 
pathways behind diseases and identify metabolites as potential biomarkers and targets for 
therapy.  
The most common analytical techniques used to acquire metabolomics data are nuclear 
magnetic resonance (NMR) spectroscopy and mass spectrometry (MS)[7, 11]. In NMR, a 
sample is submitted to a magnetic field and a radio frequency (RF) pulse is applied, causing 
the atomic nuclei to resonate at a specific frequency[12]. Some atomic nuclei, e.g. protons 
(
1
H), possess a property called spin. When such nuclei are exposed to a strong magnetic field 
(B0), their magnetic moments will align either parallel or anti-parallel of B0, yielding a lower 
or higher energy spin state, respectively. The energies from nuclei in different states cancel 
each other out; however, more protons will exist in the lower energy state, causing a residual 
component of the magnetic moment. By applying an excitation radio frequency (RF) pulse, 
nuclei can be brought to a higher energy state of resonance. Following the excitation, the 
nuclei recover to the equilibrium state and the absorbed energies are released, emitting RF 
signals. Receiver coils detect the RF signals originating from the excited nuclei, and small 
differences in resonant frequencies can yield detailed information about the sample’s 
molecular structure. The result of the analysis is an NMR spectrum, which is a plot of the 
intensity of absorption or emission as a function of the resonance frequency, which 
corresponds to the energy difference between the proton’s two spin states (Figure 2). The 
  
chemical shift scale expresses the resonance frequency as a deviation from a reference signal 
in parts per million (ppm) and is thus independent of the magnetic field strength. 
In MS, an ion source transforms the sample into volatile ions e.g. by bombarding it 
with electrons, photons, ions, molecules or thermal or electric energy[13]. The ions produced 
are then accelerated into a mass analyzer. Here, the energetically charged ions are continuosly 
detected and sorted according to their mass-to-charge ratio (m/z). Finally, the beam of ions is 
converted into an electric signal by a transducer to be processed and displayed at a further 
stage. The mass spectrometer’s response is represented in a plot of relative intensity over m/z. 
Both of the abovementioned analytical techniques have different strengths and 
weaknesses. Thus, although they can be used individually depending on the objectives of the 
metabolomics study, they complement each other. NMR provides more information on the 
chemical structure of metabolites making it easier to elucidate it[14]. Preparation of biofluid 
and tissue samples for NMR is simple and does not require time-consuming procedures as in 
MS. NMR sample preparation is also nondestructive, which enables further analyses of the 
same sample. When compared to MS, NMR is highly quantitative and reproducible[11, 15]. 
A drawback of NMR is its low sensitivity which does not make it possible to detect 
metabolites that are present in low abundance in a sample[11, 14, 15]. Limits of detection are   
in the micro- to millimolar range, while MS can detect compounds present as low as 
nanomolar or even picomolar and femtomolar concentrations depending on the method 
used[16, 17].  MS is usually combined with a chromatographic technique for prior separation 
of compounds in a sample. It provides high sensitivity and specificity, but is less useful for 
the elucidation  of chemical structure, generating information only on the elemental 
composition and some structural fragments. In addition, sample preparation usually includes 
time-consuming pretreatment such as extraction or, when separating non-volatile compounds 
using gas chromatography, derivatization.  
  
Whatever the method used to acquire metabolomics data, they all generate complex, 
high-dimensional data. In statistical terms, matrices consisting of much more variables 
(organized in columns) in relation to samples (organized in rows) will be produced. Many of 
the variables in these matrices are highly collinear, which means there will be an approximate 
linear relationship between at least some of them[18]. Classical multiple linear regression and 
similar techniques use the least squares approach (Equation 1) to fit models represented as 
y=Xβ+E, where β is a vector containing a regression coefficient for each variable in the 
matrix X, y is a vector containing a response or category for each sample and E is a residual 
matrix. Coefficients from collinear variables can compete and cancel each other out, making 
the inverse of X
T
X in Equation 1 difficult to calculate or ill-conditioned[19]. In these cases, 
dimension reduction multivariate methods, such as principle component analysis (PCA) and 
partial least squares (PLS) – discriminant analysis (DA) should be used for modelling of the 
data.  
                                                                𝛽 = (𝑋𝑇𝑋)−1𝑋𝑇𝑦                                                     (1) 
Prior to multivariate analysis, preprocessing of the data must be carried out to remove any 
variance not related to the property of interest. Several preprocessing procedures and methods 
exist that vary according to the characteristics of the data to be dealt with. Those 
characteristics are a result, to some extent, of the analytical technique used. This review 
outlines the main preprocessing steps focusing on NMR metabolomics datasets, particularly 
on those obtained from biofluids and tissue samples. A description of some of the methods 
available to carry out these procedures is also provided.  
 
Preprocessing of NMR metabolomics data 
Preprocessing is the transformationof raw data to make it apt for subsequent data analysis 
by adjusting the variability of each variable as well as that of the relationships between 
  
them[20]. It involves different procedures, each one directed to correct for different artifacts 
present in the data. Furthermore, different methods are available to carry out these procedures. 
The main steps necessary in the preprocessing of NMR data are described below. 
 
Baseline correction 
The baseline in NMR spectra consists of broad regions between peaks that do not contain 
signal of interest. Due to noise, i.e. the constant, random variation of positive and negative 
signals assumed to average to zero, the baseline will never be completely flat, but attempts 
should be made to make it as straight as possible. However, most NMR spectra display 
baseline distortion which can originate from different sources. This may be macromolecules 
that decay much faster in the time domain than those arising from the low molecular weight 
metabolites [21]. At short echo time [12] these signals from macromolecules are broad in the 
frequency domain and may alter the baseline. Other sources of baseline distortion include 
alterations in the free induction decay (FID), particularly of the first few data points[22], and 
instability in the instrument[23]. A distorted baseline alters the real intensity values in the 
spectra, resulting in less accurate peak assignment and integration. Furthermore, because most 
multivariate techniques cannot separate baselines and real signals[24], statistical results are 
affected when the baseline is not flat. Thus, appropriate baseline correction is an important 
step for removing unwanted variation. 
Baseline correction of NMR-acquired data can be carried out in either the frequency or 
time domains[22, 25]. Frequency domain baseline correction is the typical approach and it 
involves baseline estimation and its subsequent subtraction directly from the measured 
spectrum[20] (Figure 3). Alternatively, the distorted points at the beginning of the FID in the 
time domain can be reconstructed by extrapolation[26], oversampling[25] or proper data 
  
acquisition timing to remove dead time[27] (Figure 4), for example. A combination of both 
methods can also be used. Frequency domain baseline correction is easier to adapt for specific 
purposes and spectra, such as metabolomics spectra[22]. We will discuss three baseline 
estimation methods and a strategy to select an optimal one for a given study. Some of the 
methods described below make use of a prior or combined step of noise removal, or 
smoothing, when modelling the baseline.[28] 
Iterative polynomial fitting[29] aims to eliminate the true signal or peaks of interest 
from the spectrum to estimate the baseline. The total spectrum, which will be referred to as 
the measured signal (y), is fitted with a low order polynomial. The signal is considered a 
function whose equation of polynomial fitting in the concise matrix form is shown in 
Equation 2, where X is a matrix of size m ×(n+1)  whose rows are each of the j= 1, 2,…, m 
spectral points elevated from the zero to the nth power: [1 xj xj
2
 … xj
n
]. The column vector a 
represents the coefficients to be determined: a0, a1, …, an . The polynomial fitting is obtained 
through Equation 3. 
                                                                     𝑦 = 𝑋𝑎                                                               (2) 
                                                          𝑏 = 𝑋(𝑋𝑇𝑋)−1𝑋𝑇𝑦                                                     (3) 
A comparison between corresponding spectral points in the original (y0) and estimated 
signal (bk) is carried out, where k is the iteration number. Spectral points that have a higher 
value in y0 are replaced by those in bk, to obtain a new signal (yk). The process is repeated 
taking yk as the new signal until the criterion ρ (Equation 4) is met, resolving with bk as the 
estimated baseline. There is no straightforward approach to determine the optimal polynomial 
order, and so the procedure may need to be repeated with different values for the power 
parameter n before a baseline that matches the original signal well is estimated. Another 
disadvantage is that fitting a different polynomial to each spectrum may result in variance in 
  
the dataset not related to the metabolic states under study[30]. Furthermore, in theory, the 
shape of NMR drifts is not that of polynomial functions[31]. 
 
                                          𝜌 =
‖𝑏𝑘−𝑏𝑘−1‖
𝑏𝑘−1
< 0.001                                                     (4) 
 
 
Asymmetric least squares smoothing (AsLS)[32] uses the least squares algorithm to fit 
the baseline by minimizing the residuals through a vector of weights while adding a penalty to 
smooth the estimated baseline (Equation 5). The method is asymmetric as negative residuals 
are given more weight than positive ones. 
 
𝑆 = ∑ 𝑤𝑖𝑖 (𝑥𝑖 − 𝑧𝑖)
2
𝑖
+ 𝜆 ∑ (Δ2𝑧𝑖)
2
𝑖                                         (5) 
 
The first term in Equation 5 measures the fit to the original spectrum, where w is a 
vector of prior weights, x is the original spectrum and z is the estimation of the baseline in the 
current iteration (i). The second term is the smoothing penalty on z, where λ is a parameter 
that tunes the smoothing and Δ^2 zi is calculated according to Equation 6.  
 
𝛥2𝑧𝑖 = (𝑧𝑖 − 𝑧𝑖−1) − (𝑧𝑖−1 − 𝑧𝑖−2) = 𝑧𝑖 − 2𝑧𝑖−1 + 𝑧𝑖−2                            (6) 
 
A parameter p tunes the asymmetry as it is used to compute the weights according to 
whether the residuals are positive or negative as shown in Equations 7 and 8, respectively.  
     𝑤𝑖 = 1 − 𝑝                                                              (7) 
𝑤𝑖 = 𝑝                                                                 (8) 
Residuals calculated at each iteration can have different signs, leading to different 
weights (Equations 7 and 8). The process is iterated until the signs, and hence the weights, are 
  
unchanged. Using a vector of all ones for w as a starting point leads to a solution in about 10 
iterations[33]. 
Advantages of AsLS include fast computation even for large signals and the tuning of 
the flexibility and position of the baseline with the abovementioned parameters, whose use 
make results completely reproducible. However, there is no automatic way to select these 
parameters and thus it must be done subjectively based on human judgment. 
Dietrich et al. [34] introduced a derivative method involving automatic peak 
recognition followed by fitting a fifth degree polynomial to the remaining baseline and its 
subsequent subtraction from the spectrum. The noise is reduced prior to derivatization using a 
moving average filter of width k which replaces every spectral point (xj) with the average of 
the interval including xj-k to xj+k. A first derivative of the spectrum is built by replacing each 
spectral data point with the difference between its value and the value of the next point. This 
allows us to distinguish the peaks from the baseline, as differences between their neighboring 
points are generally higher than those of the baseline[35]. The power spectrum is calculated 
and accentuates the peaks from the baseline. Anything below the threshold calculated as the 
sum of the mean of the entire power spectrum and three times the standard deviation is 
considered the baseline while the rest are peaks and are discarded. The threshold is calculated 
again until all data points are below it. For all points considered peaks, if both of its neighbors 
do not exceed the final threshold, it is put back into the baseline. Similarly, baseline points 
having both neighbors above the threshold are considered peaks. The final step is the 
polynomial fitting and subtraction of the baseline. This method is fast and easily automized 
but can be unstable when the spectrum has overlapping or broad peaks [35]. 
 Liland et al. have proposed a procedure for the optimal selection of spectral baseline 
correction methods and parameters[36]. They apply this procedure on two different types of 
spectra: Raman and matrix-assisted laser desorption/ionization (MALDI)-Time of flight 
  
(TOF). The procedure is said to be applicable for multivariate spectra regardless of the 
analytical technique used for acquisition. They recommend four steps: 1) selection of a 
limited number of parameter values to test; 2) baseline correction employing different 
methods and combinations of parameter values, statistical analysis and quality assessment; 3) 
visual inspection of the baseline resulting from the combination of parameter values achieving 
the best quality measure; 4) selection of the best performing method based on the quality 
measure and its subsequent application on spectra not used for modelling. A prediction is 
made for these corrected spectra using the statistical models obtained in step 2 to validate the 
performance of the selected baseline correction method. 
 
Peak Alignment  
During spectral acquisition using NMR, peaks can shift left or right from their expected 
chemical shift due to changes in pH, temperature, inhomogeneous magnetic field and 
molecular interactions[37, 38]. This will create a variation in ppm values between spectra 
from different samples. For each spectrum included in a dataset, the signal for every 
metabolite should be aligned to the exact chemical shift to make the data comparable in 
multivariate analysis. If this is not the case, information corresponding to the same metabolite 
will be positioned in different columns of the data matrix hindering a true comparison.  
Alignment methods are used to correct differences in chemical shift. Most of these 
methods position the signals in a spectrum to fit the corresponding chemical shift in a 
reference spectrum. A type of alignment methods known as warping does this by shifting, 
compressing or stretching the data until every signal matches the location, or chemical shift, 
of the same signal in the reference without changing the order of peaks[39].  
Alignment can be carried out in two ways. The first is a global alignment in which the 
entire spectrum is corrected at once. Another approach is to divide the data into segments and 
  
align each segment separately. This is a more local approach and is more applicable to NMR 
spectra because peaks in a spectrum may not shift uniformly in direction or magnitude[20]. 
Different regions in a spectrum may exhibit peaks shifting in opposite directions or to 
different extents. However, misalignment can result if peaks are assigned into a wrong 
segment or are divided into two segments[24]. 
An example of global alignment methods is parametric time warping (PTW)[33]. PTW 
proposes a polynomial model for the warping function which is easy to interpret. The term of 
zero order, or the constant in the function, represents a shift. The first order term represents a 
compression or stretch, and higher order terms represent compression or stretches that depend 
on the variation of the spectra variable [39]. 
Correlation optimized warping (COW) was introduced by Nielsen et al.[40] for 
chromatographic data. This method uses two parameters to align spectra to match the 
reference: segment size and flexibility or slack[24, 37]. Based on the segment size, the 
spectrum is divided into local sections which will be aligned individually by compression or 
stretching. The flexibility indicates the maximum amount of data points that the segment can 
be stretched or compressed via interpolation. This process is carried out to maximize the 
overall correlation between sample and reference. 
Another local approach which segments spectra is icoshift, which was developed by 
Savorani et al.[41] for the alignment of NMR acquired metabolomics data. This method 
employs fast Fourier transforms to maximize the correlation between a spectrum and a 
reference, and here correlation is optimized for each segment as opposed to overall correlation 
as in COW. Another difference is that the segments can be user defined and do not have to be 
equal in size (Figure 5). In addition, icoshift only shifts the segments and hence does not 
affect integration for quantification purposes by variation caused by stretching or compressing 
the spectra. This algorithm has shown to be faster than COW[24, 38, 41] because it aligns all 
  
spectra simultaneously. Giskeødegård et al.[42] showed that icoshift and COW performed 
better when comparing five different alignment methods for high resolution (HR) magic angle 
spinning (MAS) MR spectra based on similarity measures between spectra and reference, 
quantification of change due to alignment and performance of PLS- DA classification models 
resulting from aligned data. Only a few of the existing alignment algorithms have been 
presented here. A more extensive list of methods has been described by Bloemberg et al[39].  
All of the abovementioned methods require a reference spectrum to align the rest of the 
spectra towards. Choosing or constructing an appropriate reference is therefore a critical step, 
and may affect the subsequent data analysis results. The reference should be the best possible 
representation of the group of spectra in the dataset in terms of number of peaks[37]. It can be 
either selected from the dataset of interest or an entirely new spectrum built by calculating a 
measure of spread of the whole dataset. Different criteria exist to select an individual 
spectrum from a dataset as a reference. It can be selected randomly as done by Pierce et al. for 
chromatographic data[43]. In cases where the spectrum that contains the most metabolite 
signals is known, it can be used as a reference.  Another approach is to use the spectrum 
which is most similar to the rest by calculating for each spectrum, its correlation with the rest 
and then averaging to obtain a single score in the way of a mean correlation per spectra[44].  
A reference as a measure of spread of an entire dataset can also be created in different 
ways. The mean spectrum usually includes all peaks appearing throughout the entire group of 
spectra. However, using this as a reference may also introduce atypical artifacts that may 
cause peak distortion after alignment[45], in addition to the mean spectrum having broad 
peaks. To avoid this, median or trimmed mean spectra can be used. 
An alternative approach typically used for NMR data to correct small misalignments is 
binning, also known as bucketing. Spectra are segmented into a desired number of bins and 
all measurements inside each bin are summed by means of the integral of the signal or area 
  
under the curve [20, 24, 45]. This method makes the data less complex and more manageable 
by reducing the number of variables, which may facilitate data analysis.  Moreover, the 
spectra are implicitly smoothed with this procedure. However, resolution will be reduced and, 
as is the case for local alignment methods, care must be taken to correctly place bins so as to 
not have peaks fall into the wrong bin or to split peaks in two (Figure 6). This can lead to loss 
of information or generation of artifacts. 
 
Normalization 
Metabolomic responses are reflected in differences in concentration of specific 
metabolites. Biological samples from which datasets are acquired regularly exhibit 
differences in overall metabolite concentrations. In the case of biofluids, dilution factors will 
not be exactly the same for each sample. For instance, the concentration of the constituents in 
urine differs according to the amount of water ingested or urinary volume excreted. In the 
same way, when analyzing tissue, the weight of prepared material may not be constant for all 
samples.  This creates variations in signal intensities attributed to amount of material analyzed 
and dilution rather than changes in metabolic responses. Normalization methods aim to 
remove this effect to make spectra comparable. Different normalization approaches include 
area normalization, probabilistic quotient normalization (PQN), range normalization and 
normalization to a reference metabolite. 
Area or integral normalization can be considered the standard for NMR-acquired 
metabolomics data[46]. The algorithm divides each data point by an equal total area, integral 
or mean of the spectrum.  Figure 7 shows a hypothetical case in which three different sets of 
spectral data points were acquired from different amounts of the same tissue sample. For two 
spectra in which one was acquired from double the amount of sample, the signal intensity 
would be expected to be double for each data point. Similarly, three times the amount of 
  
sample will yield three times the intensity. Figure 7 shows how these tissue size differences 
are eliminated when using area normalization by dividing by the sum of intensities. However, 
this method has been reported to have limitations in robustness and accuracy when extreme 
quantities of single metabolites exist in samples[46, 47]. 
PQN[46] was developed to address the issues of area normalization in NMR-acquired 
metabolomics data of urine. It assumes that changes in overall metabolite concentrations 
affect the whole spectrum, while concentration differences in individual metabolites are 
reflected in only parts of the spectrum. Those individual metabolite peak differences do not 
depend on dilution only, as assumed for all peak differences by area normalization.   The 
method follows four steps: 1) select or calculate a reference spectrum; 2) calculate the 
quotient between each of the data points of the spectrum to be normalized and the 
corresponding points in the reference spectrum; 3) find the median of these quotients and 
divide all points in the spectrum by this median; 4) repeat steps 2 and 3 for all spectra.  Care 
must be taken in using a representative reference spectrum without a large portion of specific 
metabolite concentration changes in the total signal; it may be necessary to calculate it from 
control samples.  
Min-max or range normalization[48] rescales the spectral data points to a new range, 
usually from zero to one or from one to minus one[49]. Equation 9 shows the linear 
transformation through which each of the i number of data points x in the spectrum, with 
values that range from xmin to xmax, is changed to range from newmax to newmin.  
𝑥𝑖 ≡
𝑥𝑖−𝑥𝑚𝑖𝑛
𝑥𝑚𝑎𝑥−𝑥𝑚𝑖𝑛
× (𝑛𝑒𝑤𝑚𝑎𝑥 − 𝑛𝑒𝑤𝑚𝑖𝑛) +  𝑛𝑒𝑤𝑚𝑖𝑛                             (9) 
A fourth method used for urine spectra is to express the intensity of all signals relative to  
the peak areas of the normally-occurring reference metabolite creatinine.[20]. . The rationale 
for the use of creatinine is that its excretion rate or clearance is considered to remain constant 
[50]. However, creatinine excretion may be affected by metabolic changes caused by certain 
  
diseases or in children and the elderly due to muscle mass differences [47]. Other drawbacks 
include possible interference of overlapping peaks and the pH dependence of the intensity of 
the creatinine signal[46].  
Before any normalization is attempted, it is important to consider the removal of spectral 
signals that are known to be unrelated with biological effects of interest, such as the residual 
water signal and lipid peaks arising from adipose tissue, whose intensities may interfere with 
this procedure. 
 
Scaling 
Metabolites that are more abundant will usually display larger differences among samples 
that can mask smaller, yet biologically important changes in metabolites of low abundance. 
Scaling aims to balance signal intensity variances that originate from difference in average 
abundance of metabolites. While normalization is a sample/row-wise operation, scaling is 
performed column-wise on the variables[47, 51]. Unlike normalization operations, which are 
performed independently on each sample, scaling operations depend on all samples in the 
dataset.  Typically used scaling methods include autoscaling, pareto scaling and vast 
scaling[15, 47, 52]. 
Mean centering is a column-wise centering method typically used prior to scaling. Mean 
centering transforms all values so that they vary around zero instead of around the mean 
value[15]. This corrects for the displacement between metabolites existing in high and low 
concentrations, resulting in the simplest model possible[47] (Figure 8). Mean centering is 
carried out by subtracting the column mean intensity from each individual intensity value.  
Autoscaling or standardization is a method which converts all metabolites or spectral data 
points to have unit variance. It is therefore also known as unit variance scaling. The algorithm 
divides each value in a column by the standard deviation after mean centering[20, 52]. 
  
However, variables containing only noise are given larger influence when applying this 
method[15, 20]. NMR spectra include many baseline regions with random noise, which 
makes autoscaling less suited for this type of data. 
Pareto  scaling  is  an approach which is similar to autoscaling except it uses the square 
root of the standard deviation as a scaling factor instead of the standard deviation alone[15]. 
The resulting values are more similar to the original, raw measurement. Pareto scaling is an 
intermediate between the extremes of no scaling and autoscaling; however, large biologically 
relevant variations in the data are decreased more than small variations, and so the influence 
of the former is reduced significantly when compared to the unprocessed data.  
Variable stability, or Vast scaling, is a third method that accentuates relatively stable 
metabolites that do not show large fluctuations. It is an extension of autoscaling: after mean 
centering, the data is divided by both the column standard deviation and the coefficient of 
variation (cv). A group specific cv can be calculated if a priori knowledge about sample 
groups is available. This method is not suitable for data having large induced variation and 
lacking group structure[52]. 
 
Variable selection 
Typically, when conducting metabolomics studies, previous knowledge exists about the 
origin of the analyzed samples and supervised methods are used to build models for the 
classification of samples into biological categories based on the acquired metabolic profiles. 
The biological category each sample falls into are represented using dummy variables[53]. 
For example, the code 1 can be assigned to one category and -1 to another. These codes are 
arranged in the form of a response variable (y) with rows corresponding to each sample 
(Figure 9). In most cases, not all of the chemical shift regions are informative or related to 
  
biological variances of interest. Variables that are uninformative may add noise to the model 
and if included may produce misleading results and interpretations[54]. 
Variable selection is the process of reducing the original number of variables or columns 
in the dataset by discriminating informative variables from the ones that are not related to the 
response y. Because each spectral data point region represents a metabolite, selecting 
informative variables in metabolomics datasets can be considered as selecting informative 
metabolites that are relevant to the property of interest, and can lead to the identification of 
potential biomarkers[55, 56].  
Variable selection is not a preprocessing procedure per se, as it involves statistical 
modelling in order to determine the best subset of variables. It is described here because it 
may be carried out prior to the construction of the final statistical models. However, it is 
important to keep in mind that this procedure should be regarded as being part of statistical 
analyses rather than preprocessing and requires proper validation to avoid biased results.   
The minimum redundancy-maximum relevance method uses a quantity called mutual 
information as a measure of variable importance[57]. If the values of a given variable are 
random or uniformly distributed between categories, the information that is mutual between 
the variable and the response y is zero. However, if the variable accounts for large differences 
between classes, then there is large amount of mutual information between the variable and 
the response. First developed for gene expression data, this method not only selects the 
variables most relevant to the property of interest, but it also excludes variables that provide 
the same information as others that have been selected, in this way minimizing redundancy. 
This is useful for dimensionality reduction of NMR spectra in which nearby data points are 
highly correlated. The risk in this is that different highly correlated metabolites could be 
discarded while still being involved in the pathway of a disease being studied.  
  
Variable significance can also be evaluated using permutation tests. For a given variable j, 
two different models are built: one with permuted values of j and one without. The 
performance of both models is evaluated. To do so, the models are tested on data not used for 
training, or building, the model. The model built with the training set is used to predict the 
response of each  spectrum in the test set with and without permuted j. A model quality 
measure is calculated based on the predicted value and the true value of the response for each 
spectrum. The entire process is repeated for each of the defined number of permutations. A 
mean of performance quality measures is obtained for both normal prediction and prediction 
with permuted j, which can then be compared. This method requires high computational 
power and can be very time-consuming.     
A third approach involves the calculation of a selectivity ratio for each variable based on a 
target projection model[58]. While other statistical methods produce models consisting of 
many components, target projection models are composed by a single predictive component, 
which makes them easier to interpret. From the target projection model built, explained (vexpl) 
and residual (vres) variances can be calculated for each of the p variables in the dataset. The 
selectivity ratio for each variable will then be the relationship between these variances 
(Equation 10) The higher the selectivity ratio, the more informative the variable is. However, 
a suitable threshold must be established to determine at what selectivity ratio a variable 
should be selected as important or informative. 
𝑆𝑅𝑗 =
𝑣𝑒𝑥𝑝𝑙,𝑗
𝑣𝑟𝑒𝑠,𝑗
, 𝑗 = 1,2,3, … , 𝑝                                                 (10) 
When selecting a subset of variables and building statistical models, a proper validation 
scheme should be implemented to ensure the reliability of  model performance and unbiased 
results[59, 60]. It is highly important that the scaling factors are calculated from training data 
and applied to test set data to avoid overfitting. Anderssen et al. have proposed a double-layer 
validation to avoid over-optimistic model performance [61]. 
  
 
Concluding remarks 
Metabolomics data, whether acquired by MS or NMR, is high dimensional and complex 
and requires multivariate statistical techniques for interpretation. Prior to data analysis, 
preprocessing must be carried out to remove artifacts and biologically irrelevant variance. 
Preprocessing of NMR metabolomics data includes several procedures; the optimal method to 
carry out may vary depending on the type of samples analyzed. Here, we have described some 
of the methods that have been applied for the preprocessing of NMR metabolomics data. 
Using different methods for the same preprocessing procedure may produce different results, 
and the group that works most appropriately together when applied to the dataset in question 
should be selected. It may be useful for each laboratory to establish a pipeline to choose the 
combination of preprocessing procedures and methods that will optimize NMR metabolomics 
data analysis results based on the aim of the analysis.  
The result of appropriate data preprocessing is the elimination of spectral artifacts and 
removal of irrelevant variation, making NMR spectra more comparable. It is then possible to 
proceed to analyze the data using multivariate statistical methods. The description of such 
methods are beyond the scope of this paper, and the authors refer to [24] for further 
descriptions of multivariate methods for analysis of NMR data. 
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Figures 
 
Figure 1. The Omics Cascade depicting the different molecular levels in an organism. The 
arrows represent biochemical processes through which information is transferred from one 
level to the next. Metabolomics, as the final step in the cascade, studies molecules that are 
closer to the phenotype. 
 
 
 
  
 
Figure 2. Proton high resolution (HR) magic angle spinning (MAS) magnetic resonance 
(MR) spectrum of a breast tumor biopsy.  Metabolite peaks observed include 1) β-glucose, 2) 
ascorbate, 3) lactate, 4) tyrosine, 5) creatine, 6) glutamate, 7) glycine, 8) taurine, 9) 
glycerophosphocholine, 10) phosphocholine, 11) choline, 12) methionine, 13) glutamine and 
14) alanine.   
 
 
 
 
 
Figure 3. Baseline estimation of an NMR spectrum. Reprinted from Trends in Analytical 
Chemistry, Vol 30, Liland, KH. Multivariate methods in metabolomics – from pre-processing 
to dimension reduction and statistical analysis, 827-841, Copyright 2011, with permission 
from Elsevier. 
  
 
Figure 4. Baseline correction in the time domain based on proper data acquisition timing. (a) 
Absence of dead time leads to no baseline distortion. (b) Phase errors are observed with both 
dead time and signal detection starting at time zero. (c) Baseline distortion observed when 
signal detection starts after a dead time of t0. 
 
 
 
 
Figure 5. NMR data (a) before and (b) after alignment using the icoshift algorithm. Two 
intervals of different sizes defined by the user are shown here. 
  
Reprinted from: Journal of Magnetic Resonance, Vol 202, Savorani F, Tomasi G, Engelsen 
SB. icoshift: A versatile tool for the rapid alignment of 1D NMR spectra, 190-202, Copyright 
2010 with permission from Elsevier. 
 
 
 
Figure 6. Hypothetical examples of how binning addresses peak shifts. (a) A good binning: 
each peak corresponding between the red and the blue spectra fall into the same bin. (b) 
Multiple peaks fall into the same bin. (c) The first peak of the red spectrum falls in the same 
bin of the second peak of the blue spectrum. (d) Peak shifts across the boundaries of bins. 
Reprinted from: Metabolites, Vol 3,  Vu TN, Laukens K. Getting Your Peaks in Line: A 
Review of Alignment Methods for NMR Spectral Data, 259-276, Copyright 2013 (Open 
Access). 
 
 
Figure 7. Hypothetical area normalization to eliminate variance related to the amount of 
sample analyzed. The signal intensity of three sets of spectral data points acquired using 
different amount of the same tissue sample are divided by the sum of the intensity in each set 
to make each spectrum comparable. 
 
 
 
  
 
Figure 8. Depiction of data mean centering in two dimensions. Original data (black axis) vary 
around the mean. Mean centering shifts data left and down so that zero becomes the new 
centroid (red axis).  
 
 
Figure 9. Representation of a dataset consisting of 20 samples or spectra and 10 variables or 
spectral data points. The response variable y contains dummy variables where 1 represents a 
particular category and -1 another, for example presence and absence of a certain disease, 
respectively. 
